Tabula Rasa HealthCare Inc (NASDAQ:TRHC) Shares Acquired by Parametric Portfolio Associates LLC

Share on StockTwits

Parametric Portfolio Associates LLC grew its holdings in Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 21.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 24,364 shares of the company’s stock after buying an additional 4,304 shares during the period. Parametric Portfolio Associates LLC owned 0.11% of Tabula Rasa HealthCare worth $1,216,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Jennison Associates LLC raised its position in shares of Tabula Rasa HealthCare by 3.8% in the second quarter. Jennison Associates LLC now owns 918,893 shares of the company’s stock valued at $45,880,000 after buying an additional 33,282 shares during the last quarter. First Trust Advisors LP raised its position in shares of Tabula Rasa HealthCare by 722.5% in the second quarter. First Trust Advisors LP now owns 418,301 shares of the company’s stock valued at $20,886,000 after buying an additional 367,445 shares during the last quarter. Rice Hall James & Associates LLC raised its position in shares of Tabula Rasa HealthCare by 110.5% in the second quarter. Rice Hall James & Associates LLC now owns 370,173 shares of the company’s stock valued at $18,483,000 after buying an additional 194,298 shares during the last quarter. Janus Henderson Group PLC acquired a new stake in shares of Tabula Rasa HealthCare in the second quarter valued at about $17,074,000. Finally, Peregrine Capital Management LLC raised its position in shares of Tabula Rasa HealthCare by 20.7% in the second quarter. Peregrine Capital Management LLC now owns 335,984 shares of the company’s stock valued at $16,776,000 after buying an additional 57,639 shares during the last quarter. Institutional investors and hedge funds own 98.75% of the company’s stock.

A number of equities research analysts recently issued reports on the stock. Stifel Nicolaus raised shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating and upped their price objective for the company from $50.00 to $75.00 in a report on Friday, August 30th. ValuEngine raised shares of Tabula Rasa HealthCare from a “buy” rating to a “strong-buy” rating in a report on Wednesday, September 4th. Zacks Investment Research lowered shares of Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a report on Thursday. Finally, BidaskClub lowered shares of Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research note on Friday. Three research analysts have rated the stock with a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $78.26.

In other news, CFO Brian W. Adams sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $60.00, for a total value of $600,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Orsula V. Knowlton sold 8,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $54.85, for a total transaction of $438,800.00. The disclosure for this sale can be found here. In the last three months, insiders sold 78,000 shares of company stock valued at $4,534,610. Insiders own 11.80% of the company’s stock.

NASDAQ TRHC opened at $51.38 on Friday. The firm has a 50 day simple moving average of $56.29 and a 200-day simple moving average of $53.54. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.90 and a current ratio of 1.97. Tabula Rasa HealthCare Inc has a one year low of $40.86 and a one year high of $83.37. The firm has a market cap of $1.14 billion, a price-to-earnings ratio of 233.59 and a beta of 1.66.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.35 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.06 by $0.29. Tabula Rasa HealthCare had a negative net margin of 7.09% and a positive return on equity of 3.63%. The business had revenue of $76.26 million during the quarter, compared to analyst estimates of $70.40 million. During the same quarter last year, the firm posted $0.20 earnings per share. The business’s revenue for the quarter was up 56.9% compared to the same quarter last year. Equities analysts predict that Tabula Rasa HealthCare Inc will post -0.15 EPS for the current fiscal year.

Tabula Rasa HealthCare Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems.

Recommended Story: Average Daily Trade Volume Explained

Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Parametric Portfolio Associates LLC Purchases 3,352 Shares of Acceleron Pharma Inc
Parametric Portfolio Associates LLC Purchases 3,352 Shares of Acceleron Pharma Inc
Tabula Rasa HealthCare Inc  Shares Acquired by Parametric Portfolio Associates LLC
Tabula Rasa HealthCare Inc Shares Acquired by Parametric Portfolio Associates LLC
Vanguard Group Inc. Has $70.92 Million Stock Position in Northstar Realty Europe Corp
Vanguard Group Inc. Has $70.92 Million Stock Position in Northstar Realty Europe Corp
153,444 Shares in Qudian Inc –  Acquired by Parametric Portfolio Associates LLC
153,444 Shares in Qudian Inc – Acquired by Parametric Portfolio Associates LLC
Vanguard Group Inc. Has $71.93 Million Holdings in Stars Group Inc
Vanguard Group Inc. Has $71.93 Million Holdings in Stars Group Inc
Cytokinetics, Inc.  Shares Bought by Parametric Portfolio Associates LLC
Cytokinetics, Inc. Shares Bought by Parametric Portfolio Associates LLC


© 2006-2019 Ticker Report